HIV-1 replication

Somatic Cell and Molecular Genetics

Volumn 26, Issue 1-6, 2001, Pages 13-33

  Freed, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; INTEGRASE; NEF PROTEIN; POL PROTEIN; PROTEIN P1; PROTEIN P2; PROTEIN P6; PROTEIN PR160; PROTEIN PR55; PROTEIN PRECURSOR; RNA DIRECTED DNA POLYMERASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

CATALYSIS; DISULFIDE BOND; FRAMESHIFT MUTATION; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LONG TERMINAL REPEAT; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RETROVIRUS; REVIEW; RNA TRANSLATION; RNA TRANSPORT; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0035525978     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021070512287     Document Type: Review

References (70)

1. Freed EO, Martin MA. HIVs and their replication. In: Knipe DM, Howley PM, Griffin D, Lamb RA, Roizman B, Martin MA, Straus SE, eds. Fields Virology, 4th Ed. Philadelphia: Lippincott, Williams, and Wilkins, 2001:1971-2041.
2. Bour S, Geleziunas R, Wainberg MA. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev 1995; 59:63-93.
3. Kwong PD, Wyatt R, Robinson J et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998; 393:648-659.
4. Hoxie JA, Alpers JD, Rackowski JL et al. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 1986; 234:1123-1127.
5. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657-700.
6. Doms RW, Peiper SC. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology 1997; 235:179-90.
7. O'Brien WA, Koyanagi Y, Namazie A et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990; 348:69-73.
8. Endres MJ, Clapham PR, Marsh M et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996; 87:745-756.
9. Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273:1856-1862.
10. Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-377.
11. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725.
12. Chan DC, Fass D, Berger JM et al. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997; 89:263-273.
13. Weissenhorn W, Dessen A, Harrison SC et al. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997; 387:426-430.
14. Bullough PA, Hughson FM, Skehel JJ et al. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994; 371:37-43.
15. Telesnitsky A, Goff SP. Reverse transcription and the generation of retroviral DNA. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1997:121-160.
16. Arnold E, Jacobo-Molina A, Nanni RG et al. Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature 1992; 357:85-89.
17. Zennou V, Petit C, Guetard D et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000; 101:173-185.
18. Temin HM. Retrovirus variation and reverse transcription: Abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci USA 1993; 90:6900-6903.
19. Pathak VK, Hu W-S. "Might as well jump!" Template switching by retroviral reverse transcriptase, defective genome formation, and recombination. Semin Virol 1997; 8:141-150.
20. Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995; 69:5087-5094.
21. Bukrinsky MI, Haggerty S, Dempsey MP et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365:666-669.
22. Freed EO. HIV-1 Gag proteins: Diverse functions in the virus life cycle. Virology 1998; 251:1-15.
23. Gallay P, Hope T, Chin D, Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 1997; 94:9825-9830.
24. Brown PO. Integration. In: J. M. Coffin, Varmus HE, eds. Retroviruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1997:161-203.
25. Chen H, Wei SQ, Engelman A. Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome. J Biol Chem 1999; 274:17358-17364.
26. Wei SQ, Mizuuchi K, Craigie R. A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J 1997; 16:7511-7520.
27. Farnet CM, Bushman FD. HIV cDNA integration: Molecular biology and inhibitor development. AIDS 1996; 10:S3-11.
28. Ross EK, Buckler-White AJ, Rabson AB et al. Contribution of NF-kB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: Distinct patterns of viral growth are determined by T-cell types. J Virol 1991; 65:4350-4358.
29. Dayton AI, Sodroski JG, Rosen CA et al. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 1986; 44:941-947.
30. Fisher AG, Feinberg MB, Josephs SF et al. The trans-activator gene of HTLV-III is essential for virus replication. Nature 1986; 320:367-371.
31. Berkhout B, Silverman RH, Jeang K-T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989; 59:273-282.
32. Wei P, Garber ME, Fang SM et al. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998; 92:451-462.
33. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993; 67:6365-6378.
34. Pollard VW, Malim MH. The HIV-1 Rev protein. Annu Rev Microbiol 1998; 52:491-532.
35. Maldarelli F, Martin MA, Strebel K. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: Novel level of gene regulation. J Virol 1991; 65:5732-5743.
36. Rosen CA, Terwilliger E, Dayton A, Sodroski JG, Haseltine WA. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci USA 1988; 85:2071-2075.
37. Bray M, Prasad S, Dubay JW et al. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA 1994; 91:1256-1260.
38. Swanstrom R, Wills JW. Synthesis, assembly, and processing of viral proteins. In: Coffin H, Varmus HE, eds. Retroviruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1997:263-334.
39. Turner BG, Summers MF. Structural biology of HIV. J Mol Biol 1999; 285:1-32.
40. Zhou W, Resh MD. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol 1996; 70:8540-8548.
41. Facke M, Janetzko A, Shoeman RL et al. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol 1993; 67:4972-4980.
42. Freed EO, Orenstein JM, Buckler-White AJ et al. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol 1994; 68:5311-5320.
43. Berkowitz R, Fisher J, Goff SP. RNA packaging. Curr Top Microbiol Immunol 1996; 214:177-218
44. Rein A, Henderson LE, Levin JG. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication. Trends Biochem Sci 1998; 23:297-301.
45. Kaye JF, Lever AM. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation. J Virol 1998; 72:5877-5885.
46. Campbell S, Vogt VM. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol 1995; 69:6487-6497.
47. Freed EO, Martin MA. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem 1995; 270:23883-23886.
48. Murakami T, Freed EO. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol 2000; 74:3548-3554.
49. Murakami T, Freed EO. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci USA 2000; 97:343-348.
50. Gottlinger HG, Dorfman T, Sodroski JG et al. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 1991; 88:3195-3199.
51. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 1995; 69:6810-6818.
52. Garnier L, Wills JW, Verderame MF et al. WW domains and retrovirus budding. Nature 1996; 381:744-745.
53. Vogt VM. Ubiquitin in retrovirus assembly: Actor or bystander? Proc Natl Acad Sci USA 2000; 97:12945-12947.
54. Wlodawer A, Erickson JW. Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem 1993; 62:543-585.
55. Yeager M, Wilson-Kubalek EM, Weiner SG et al. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: Implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A 1998; 95:7299-7304.
56. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science 1999; 283:80-83.
57. Franke EK, Yuan HE, Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994; 372:359-362.
58. Luban J, Bossolt KL, Franke EK et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993; 73:1067-1078.
59. Grattinger M, Hohenberg H, Thomas D et al. In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. Virology 1999; 257:247-260.
60. Cullen BR. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell 1998; 93:685-692.
61. Strebel K, Klimkait T, Martin MA. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 1988; 241:1221-1223.
62. Gottlinger HG, Dorfman T, Cohen EA et al. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci USA 1993; 90:7381-7385.
63. Margottin F, Bour SP, Durand H et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1998; 1:565-574.
64. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995; 69:6705-6711.
65. Simon JH, Gaddis NC, Fouchier RA et al. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 1998; 4:1397-1400.
66. Aiken C, Konner J, Landau NR et al. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994; 76:853-864.
67. Collins KL, Chen BK, Kalams SA et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998; 391:397-401.
68. Kestler HW, III, Ringler DJ, Mori K et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991; 65:651-62.
69. Marsh JW. The numerous effector functions of Nef. Arch Biochem Biophys 1999; 365:192-198.
70. Fletcher TM, 3rd, Brichacek B, Sharova N et al. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 1996; 15:6155-6165.